Outset Medical Inc
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
OM$4.12-2.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Stockholders’ Equity
| Common Stock · AdditionalPaid-in · AccumulatedOtherComprehensive · Accumulated · TotalStockholders' | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Income (Loss) | Deficit | Equity | |
| Balance as of December 31, 2021 | 47,241 | $47 | $1,000,212 | $(184) | $(625,994) | $374,081 |
| Issuance of common stock through employee stock purchase plan | 193 | — | 4,202 | — | — | 4,202 |
| Issuance of common stock for settlement of RSUs | 241 | — | — | — | — | — |
| Stock option exercises | 790 | 1 | 3,839 | — | — | 3,840 |
| Stock-based compensation expense | — | — | 27,203 | — | — | 27,203 |
| Unrealized loss on available-for-sale securities | — | — | — | (380) | — | (380) |
| Net loss | — | — | — | — | (162,956) | (162,956) |
| Balance as of December 31, 2022 | 48,465 | $48 | $1,035,456 | $(564) | $(788,950) | $245,990 |
| Issuance of common stock through employee stock purchase plan | 559 | 1 | 7,509 | — | — | 7,510 |
| Issuance of common stock for settlement of RSUs | 708 | — | — | — | — | — |
| Stock option exercises | 585 | 1 | 2,916 | — | — | 2,917 |
| Stock-based compensation expense | — | — | 38,634 | — | — | 38,634 |
| Unrealized gain on available-for-sale securities | — | — | — | 632 | — | 632 |
| Net loss | — | — | — | — | (172,797) | (172,797) |
| Balance as of December 31, 2023 | 50,317 | $50 | $1,084,515 | $68 | $(961,747) | $122,886 |
| Issuance of common stock through employee stock purchase plan | 1,040 | 1 | 2,200 | — | — | 2,201 |
| Issuance of common stock for settlement of RSUs | 1,515 | 2 | 293 | — | — | 295 |
| Stock option exercises | 72 | — | 83 | — | — | 83 |
| Stock-based compensation expense | — | — | 29,356 | — | — | 29,356 |
| Unrealized loss on available-for-sale securities | — | — | — | (26) | — | (26) |
| Net loss | — | — | — | — | (127,976) | (127,976) |
| Balance as of December 31, 2024 | 52,944 | $53 | $1,116,447 | $42 | $(1,089,723) | $26,819 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.